Cargando…
A review of rabeprazole in the treatment of acid-related diseases
Rabeprazole is a proton pump inhibitor. Pharmacodynamic data show rabeprazole can achieve optimal acid suppression since the first administration and can maintain this advantage in the following days of therapy. Moreover, rabeprazole has the highest pKa (~ 5.0, the pH at which a drug becomes 50% pro...
Autores principales: | Pace, Fabio, Pallotta, Stefano, Casalini, Stefania, Porro, Gabriele Bianchi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386363/ https://www.ncbi.nlm.nih.gov/pubmed/18488081 |
Ejemplares similares
-
Early effect on intragastric pH of oral administration of rabeprazole with mosapride compared with rabeprazole alone
por: Iida, Hiroshi, et al.
Publicado: (2017) -
Adalimumab for the treatment of Crohn’s disease
por: Cassinotti, Andrea, et al.
Publicado: (2008) -
Certolizumab pegol: an evidence-based review of its place in the treatment of Crohn’s disease
por: Cassinotti, Andrea, et al.
Publicado: (2007) -
In Vitro Effects of Rabeprazole on Human Pylorus Tone
por: Yaşar, Necdet Fatih, et al.
Publicado: (2015) -
Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
por: Ochoa, Dolores, et al.
Publicado: (2020)